Condensed Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Cash flows from operating activities:
Net loss	$ (8,819,094)	$ (6,502,345)
Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash interest expense		122,753
Share-based compensation	578,802	30,619
Depreciation	11,041	1,810
Write-off of deferred financing costs		1,901
Changes in operating assets and liabilities
Prepaid expenses	310,714	46,393
Accounts payable	765,198	642,054
Accrued expenses	(66,484)	898,675
Other non-current assets	(26,880)
Net cash used in operating activities	(7,246,703)	(4,758,140)
Cash flows from investing activities:
Purchase of property and equipment	(15,132)
Net cash used in investing activities	(15,132)
Cash flows from financing activities:
Costs associated with the issuance of common stock	(38,747)
Deferred financing costs		(67,675)
Proceeds from convertible notes payable		5,500,000
Net cash (used in) provided by financing activities	(38,747)	5,432,325
Net (decrease) increase in cash and cash equivalents	(7,300,582)	674,185
Cash and cash equivalents, beginning of period	15,644,355	1,834,018
Cash and cash equivalents, end of period	$ 8,343,773	2,508,203
Supplemental non-cash financing transactions:
Accretion of issuance costs on Series A Convertible Redeemable Preferred stock		7,420
Accretion of issuance costs on Series B Convertible Redeemable Preferred stock		$ 18,254